Cue Biopharma, Inc. (CUE)

25.52 -2.36 (-8.46%) USD  |  NASDAQ  |  Aug 31, 16:00
25.70 +0.18 (+0.71%) After-Hours: 20:00
More

Cue Biopharma Cash from Operations (Annual) : -21.69M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -21.69M
December 31, 2024 -36.33M
December 31, 2023 -39.96M
December 31, 2022 -41.81M
December 31, 2021 -38.84M
December 31, 2020 -32.49M
Date Value
December 31, 2019 -30.80M
December 31, 2018 -26.41M
December 31, 2017 -12.19M
December 31, 2016 -5.968M
December 31, 2015 -1.658M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 127.04M
Fortress Biotech, Inc. -71.34M
Equillium, Inc. -22.75M
Legend Biotech Corp. -100.46M
Nurix Therapeutics, Inc. -249.46M